Skip to content

Taurine review leaves its value for long COVID unresolved

The review links long COVID with lower blood taurine, but direct evidence of symptom relief remains unclear.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Supplementation trials reported improvements in several markers relevant to long COVID. However, the abstract does not establish that those trials enrolled people with long COVID. A separate analysis found lower blood taurine in people with persistent symptoms. This association cannot show that a taurine supplement would improve their symptoms.

Keep in mind

The abstract does not describe trial populations, durations or comparators, or report direct long COVID symptom benefits. Blood-level associations cannot establish causation.

THE NUMBERS, WITH CONTEXT

What researchers found

SMD −0.35 (95% CI −0.63 to −0.08)

Lower plasma taurine in long COVID

During COVID recovery, versus symptom-free recovered people; sampling times unspecified. SMD expresses the group difference in standard-deviation units; the confidence interval describes uncertainty around this estimate.

BMC Infect Dis, 2026 · Original source ↓

What supplementation studies reported

The supplementation trials reported improvements in metabolic, inflammatory and oxidative-stress markers, blood pressure and exercise capacity. Effects on thinking and memory were not statistically significant, leaving that outcome uncertain.

What the blood comparison can show

Lower blood taurine was associated with persistent symptoms after COVID. This comparison did not test supplementation, so it cannot establish whether raising taurine levels would change symptoms or recovery.

CHECK THE ORIGINAL

The original publication

Taurine supplementation as a therapeutic strategy for cellular senescence and chronic inflammation in long COVID: a systematic review and meta-analysis.

Wang K, Ma CH, Khoramjoo M et al.
BMC Infect Dis · 2026

PubMed ID
41803812
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.